← Back to news

Markets

Teledyne Technologies (TDY) Reported Robust Organic Growth in Q1

Y

Why The Secret CFO calls this finance leader ‘the most AI-pilled CFO’

Y

Cooke nets Mowi salmon farms in Canada

Y

Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?

Y

Is Takeda Pharmaceutical Company Limited (TAK) Stock Positioned for Growth After Strong LATITUDE Atlas Study Data?

Y

Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036

Y

GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share

Y

3 Dividend Stocks Worth Buying More of While the Market Is Distracted

Y

Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data?

Y

Microsoft Heads for Biggest Monthly Loss Since Dot-Com Burst

Y

Is BioAge Labs, Inc. (BIOA) Stock Positioned for Growth With New Phase 2 Cardiovascular Study Initiation?

Y

Comcast's NBCU split makes Wall Street's math easier

Y

Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets?

Y

Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity?

Y

Is Teva Pharmaceutical Industries Limited (TEVA) Stock Undervalued After Recent Pullback and Vitiligo Program Update?

Y

Warren Buffett Says This ETF Is Perfect for Everyday Investors

Y

Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?

Y

Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?

Y

Is BeOne Medicines AG (ONC) Stock Positioned for Growth After Encouraging ASCO Cancer Data?

Y

Zai Lab Limited (ZLAB) Gains EMA Orphan Drug Designation for DLL3-Targeting Cancer Therapy

Y

Despite Dropping 26% This Year, Microsoft is a No-Brainer Buy

Y

Is Tyra Biosciences, Inc. (TYRA) Stock a Biotech Opportunity Ahead of Key SURF302 Trial Data?

Y

Inflation in Eurozone’s Biggest Economies Cools More Than Expected

Y

Is Syndax Pharmaceuticals, Inc. (SNDX) Stock Still a Biotech Opportunity After Revised AML Market Estimates?

Y

Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?

Y

Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential

Y

Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential?

Y

Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential?

Y

3 stocks you’ll wish you bought on SpaceX’s nightmare 2-week crash — 1 has 257% upside according to analysts

Y

Joby, Toyota announce joint venture for air taxi production

Y

Grantham Warns Of Biggest Bubble In History, Again

S

OpenAI Could Delay Its IPO Until 2027. What That Means for Microsoft Stock.

Y

Dear Palo Alto Networks Shareholders - Next Stop $400 Per Share

Y

Why the Best LTL Carriers Are Built, Not Bought

Y

Think you can outsmart the market by letting AI pick stocks? A new study says don’t bother — you can’t beat buy-and-hold

Y

Saia REV: Rapid, Expanded and Visible

Y

The New ‘Bootstrap’ to the American Dream: Deep Cleaning Cars

Y

Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent Court Ruling?

Y

Ross Stores (ROST) Rose on a Favorable Consumer Environment

Y

US egg groups reach deal on pricing probe

Y

Jack in the Box shares extend rally as short squeeze gathers momentum (JACK)

Y

Magnificent Seven Value Drops $2.3 Trillion In June

Y

Stock Futures Fumble Early Gains

Y

MKS (MKSI) Advanced on Sales Strength

Y

Joby Aviation shares gain after forming manufacturing joint venture with Toyota (JOBY)

Y

Should You Chase The Breakout In AeroVironment (AVAV) Stock?

Y

What Does the Sale of Slide Insurance Stock Worth $343,000 by the COO Mean for Investors?

Y

Adobe vs. ServiceNow: Which Technology Stock Is a Better Buy in 2026?

Y

4 Ways to Own Anthropic Before It Goes Public

Y

JP Morgan’s Top 3 Stocks for 2026: The Halftime Scorecard

Y